Nortis Lifesciences Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.55 M
About Nortis Lifesciences Llp
Nortis Lifesciences Llp (NLL) is 7 Year, 9 Months old Limited Liability Partnership 04 May 2017. Its registered office is in South West Delhi, Delhi, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
-
Location
South West Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAJ-3316
-
Incorporation Date
04 May 2017
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Delhi
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Nortis Lifesciences Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gupta
|
Designated Partner | 04-May-2017 | Current |
|
Meenakshi Gupta
|
Designated Partner | 04-May-2017 | Current |
|
Rupesh Bountra
|
Designated Partner | 01-Feb-2018 | Current |
Financial Performance of Nortis Lifesciences Llp.
Enhance accessibility to Nortis Lifesciences Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nortis Lifesciences Llp?
Unlock access to Nortis Lifesciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Glensmith Labs Private LimitedSanjay Gupta is a mutual person
-
Skymap Packaging Private LimitedSanjay Gupta and Meenakshi Gupta are mutual person
-
Skymap Lifesciences Private Limited
Sanjay Gupta and Meenakshi Gupta are mutual person
-
Skymap Pharmaceuticals Private Limited
Sanjay Gupta is a mutual person
-
Skymap Welfare Foundation
Sanjay Gupta and Meenakshi Gupta are mutual person
-
Mks Healthcare LlpSanjay Gupta and Meenakshi Gupta are mutual person
Charges (Loans)
₹0.55 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2018 | Hdfc Bank Limited | ₹0.55 M | Open |
How Many Employees Work at Nortis Lifesciences Llp?
Nortis Lifesciences Llp has a workforce of 56 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nortis Lifesciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nortis Lifesciences Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.